12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.

      Mycoses
      Amphotericin B, therapeutic use, Antifungal Agents, Drug Therapy, Combination, Female, Humans, Leukemia, Myeloid, Acute, complications, Liposomes, Middle Aged, Mucormycosis, drug therapy, Rhizomucor, classification, genetics, isolation & purification, Treatment Outcome, Triazoles

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The combination of resection of infected tissue and antifungal therapy is the treatment of choice in mucormycosis. In disseminated mucormycosis, where surgery is impossible, the mortality is almost 90%. We report the first case of disseminated mucormycosis that was cured with a combination therapy of liposomal amphotericin B and posaconazole without surgical intervention.

          Related collections

          Author and article information

          Comments

          Comment on this article